COMMUNIQUÉS West-GlobeNewswire

EDAP TMS SA : EDAP Announces FDA Clearance for Focal One®
07/06/2018
AUSTIN, TX, LYON, FRANCE -- JUNE 7, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global leader in therapeutic ultrasound, today announced that it has received 510(k) clearance from the US Food and Drug [...]
Helix BioPharma Corp. Closes Private Placement
07/06/2018
RICHMOND HILL, Ontario, June 07, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]
Intercept to Present at Upcoming Conference
07/06/2018
NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]
Adamas to Present at Two Upcoming Investor Conferences
07/06/2018
EMERYVILLE, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that Gregory T. Went, Ph.D., the company’s Founder, Chairman and Chief Executive Officer, is scheduled to [...]
AIT Therapeutics Announces Change to Fiscal Year End and Financial Results Conference Call and Webcast for the Three Months Ended March 31, 2018
07/06/2018
Call scheduled for Thursday, June 14, 2018 at 8:30am Eastern Time NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled [...]
The Cooper Companies Announces Second Quarter 2018 Results
07/06/2018
PLEASANTON, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced financial results for the fiscal second quarter ended April 30, 2018. Revenue increased 21% year-over-year to $ [...]
Acura Pharmaceuticals Announces Fourth Quarter 2017 and Full Year 2017 Financial Results
07/06/2018
PALATINE, Ill., June 07, 2018 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (OTC PINK:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and [...]
Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance
07/06/2018
Cash Expected to Enable Company to Fund Operations into Second Quarter 2019 PRINCETON, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX), a women’s healthcare company, today announced [...]
Novartis announces JCO publication of Lutathera® NETTER-1 data showing significantly longer time to deterioration of key quality of life measures in patients with progressive midgut NETs
07/06/2018
Patients reported prolonged maintenance of global health status[1](overall health) Longer time to deterioration (TTD) seen across multiple clinically relevant symptom categories including diarrhea, fatigue and pain[1] [...]
Paratek Demonstrates Breadth of Omadacycline Clinical and Microbiological Data at ASM Microbe 2018
07/06/2018
Poster presentations will include new analysis of efficacy against drug resistant S. aureus in skin infections BOSTON, June 07, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK) announced today that [...]
ADMA Biologics Announces Proposed Public Offering of Common Stock
07/06/2018
RAMSEY, N.J. and BOCA RATON, Fla., June 07, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”) announced today that it has commenced an underwritten public offering of its common stock [...]
Inspire Medical Systems, Inc. Reports First Quarter 2018 Financial Results
07/06/2018
MINNEAPOLIS, June 07, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]
Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership for ADU-214 in Combination with Nivolumab
07/06/2018
BERKELEY, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced the recent initiation of a Phase 1b study of ADU-214 (JNJ-64041757) in combination with nivolumab for the treatment [...]
Spectral Announces Voting Results of Annual Meeting
07/06/2018
TORONTO, June 07, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:EDT) (OTCQX:EDTXF), a Phase III company developing the first treatment for patients with septic shock guided by a [...]
Trillium Dental Celebrates Grand Opening of Eighth Location in Ottawa
07/06/2018
OTTAWA, June 07, 2018 (GLOBE NEWSWIRE) -- Trillium Dental ®, recognized as Ottawa’s largest name in dentistry, celebrated the grand opening of its newest dental clinic located at 1110 Carp Road, in Stittsville with a [...]
Grant of Restricted Stock Units and Warrants to Genmab employees
07/06/2018
Company Announcement Copenhagen, Denmark; June 7, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 5,305 restricted stock units and 14,714 warrants to [...]
PACE Consultants Dorothy Ginsberg and Mandy Hurley Join Tabula Rasa HealthCare
07/06/2018
Capstone Performance System subsidiary to offer expanded PACE Technical Assistance Center ST. LOUIS and MOORESTOWN, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Capstone Performance Systems, a Tabula Rasa HealthCare (NASDAQ: [...]
Syapse Launches Precision Medicine Council to Advance Health System Adoption of Precision Oncology
07/06/2018
A group of the nation’s leading health systems will share best practices and strategies to accelerate precision medicine SAN FRANCISCO, June 07, 2018 (GLOBE NEWSWIRE) -- Syapse, the leading precision medicine company, [...]
Photocure ASA: Mandatory notification of trade
07/06/2018
Jan H. Egberts, Chairperson of the Board of Photocure ASA and primary insider in Photocure ASA, has on 7 June 2018 purchased 12,500 shares in Photocure ASA at a price of NOK 27.6687 per share. Following the transaction [...]

Pages